Komori
Jtp (2488) · RiskDropped

Risk of failing to obtain or renew construction and medical-device permits

First written in FY2016. 2 of 5 entries say "Restated". Latest entry: FY2020.

5entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2016 – FY2017MitigatedFY2018RestatedFY2019 – FY20202016: 120162017: 120172018: 120182019: 120192020: 12020
Same theme, other companies
Risk of failing to obtain or renew construction and medical-device permitsA theme 2 companies write about · 2 as a headwind · 0 as a tailwind

0 other companies' latest entry also says "Dropped".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2020DroppedAnnual report
    No explicit disclosure of the risk of failure to obtain or renew construction and medical device-related licenses and permits was identified in the risk disclosures for the current fiscal year.
  2. FY2019RestatedAnnual report

    「Under the Construction Business Act, the Group has obtained from the Tokyo Metropolitan Government licenses for electrical construction and telecommunications construction. Under the Pharmaceutical and Medical Devices Act, it has obtained licenses for medical device repair, medical device sales, medical device leasing, Type 1 medical device marketing, and medical device manufacturing.」

    The company describes its possession of construction and medical device-related licenses and permits while continuing to identify the risk of losing bidding opportunities in regions where the required licenses have not been obtained and the risk of being unable to renew them.
  3. FY2018MitigatedAnnual report

    「Under the Construction Business Act, the Group has obtained from the Tokyo Metropolitan Government licenses for electrical construction and telecommunications construction. Under the Pharmaceutical and Medical Devices Act, it has obtained licenses for medical device repair, medical device sales, medical device leasing, Type 1 medical device marketing, and medical device manufacturing.」

    Obtaining a Type 1 medical device marketing license and registering as a medical device manufacturer expanded the scope of the Group's response to medical device-related licensing requirements. However, the company continues to disclose risks such as an inability to renew licenses.
  4. FY2017RestatedAnnual report

    「If these licenses cannot be renewed for any reason, not only due to a fault on the part of the Group, the Group will be unable to undertake maintenance and repair work from these medical device manufacturers.」

    The company continues to identify the risk of losing order opportunities due to failure to obtain or renew construction and medical device-related licenses and permits.
  5. FY2016First statedAnnual report

    「The company conducts medical device repair, sales and leasing operations under the licenses for the medical device repair, sales and leasing businesses. If these licenses cannot be renewed for any reason, not only due to a fault on the part of the Group, the Group will be unable to undertake maintenance and repair work from these medical device manufacturers.」

    The company identifies the loss of bidding opportunities due to failure to obtain licenses and the contraction of the business due to an inability to renew licenses as risks.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Jtp's next results are scheduled for 2026-11-10. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.